Navigation Links
Common, cheaper drugs could be used to treat hypertension

Hypertension or high blood pressure as it is commonly known is a silent killer because it often goes unnoticed. It is not a life threatening disease. However, it can lead to a lot of complications such as heart attack, stroke, and // kidney failure if left untreated. Fortunately, it can be diagnosed by a very simple out patient examination and treatment involves the use of anti-hypertensive medication.

Two inexpensive, but widely overlooked drugs may help many patients who continue to have high blood pressure despite taking standard blood pressure medications, according to research by Indiana University School of Medicine scientists.

Amiloride and spironolactone, drugs that increase the rate of urine formation following administration have been studied by researchers in a group of African-American patients with high blood pressure. It is noteworthy to remember that Amiloride and spironolactone have been available for many years but less commonly prescribed as far as hypertension is concerned.

In the study of 98 patients, some were given one of the two drugs, some were given both, and some were given a placebo. All of the patients continued to take their standard blood pressure medication. On average, blood pressures of the patients taking either amiloride or spironolactone individually, or both drugs, dropped significantly. Moreover, the incidence of side effects in this group was significantly lower.

"The kidneys do an incredible job of holding on to sodium, which was important to the survival of our early ancestors who lived in a salt-poor world, but today there's so much salt in the food we eat that the kidneys end up holding onto too much sodium," said Dr. Pratt. The result, he said, can be high blood pressure – also known as hypertension.

It is a general clinical practice to prescribe higher doses of the medicine already being used, or add in a new blood pressure drug that could be expensive to patients
'"/>




Page: 1 2

Related medicine news :

1. China to make cheaper version of GSK’s flu dru
2. Cancer drugs in development nearly doubled since 1995
3. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
4. African HIV strains more resistant to anti HIV drugs
5. Right drugs drastically cut stroke risk
6. Relating heart protection and antihypertensive drugs
7. Enzyme may be target for obesity drugs
8. New HIV cases resist drugs
9. Relief to pregnant women using fertility drugs
10. AIDS drugs linked to heart attack risk
11. FDA debates status of decongestant drugs
Post Your Comments:
(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...s due to medical errors are on the rise. Medical e...given on the drug labels. Food and Drug Administra...t section //thereby making it easy for the doctors...re they could assess a drug as completely safe for...
...ly suffering from terminal cancer. The zoo officia... as comfortable and pleasant as possible. // A lar...k of the animal, which has been developing rapidly...rformed to remove the node, the animal is not expe...
...sia and many countries fear that it might one day ...e been done to develop a new dug to combat the dis...institute have found that Sambucol (an extract fro...n reducing the spread of virus in the cells. <...
...samples and their personal information about their...ation to one of the two biggest medical research p... American Project. The American project is still i...tarted very soon. The Project would be collecting ...
Other Medicine News:Health News:New Rule Results In The Complete Makeover In The Field Of Drug Advertising 2
(Date:10/9/2008)...ranslational Science Institute, Navigenics, Affyme...tudy, SAN DIEGO, Oct. 9 /- A consort...s have joined forces in a first-of-its-kind,resear...al genetic testing,on people who choose to receive...for developing certain diseases., Sponsored by Sc...
(Date:10/8/2008)...s May Someday Inform Treatments for Spinal Cord, O...wswire-USNewswire/ -- A protein that enables,nerve...role in controlling,the developing nervous system....ections to form among nerve cells may provide a ba...r injuries to their nervous system,including spin...
(Date:10/8/2008)...cal program to evaluate TAXUS(R) Element(TM) Plati..., NATICK, Mass., Oct. 8 /-... announced that it has completed enrollment in,the... third-generation,TAXUS(R) Element(TM) paclitaxel-...am has enrolled nearly 1,500 patients at 100 U.S. ...
(Date:10/7/2008)..., Oct. 7 /- Prometheus Laboratories I...ounced findings from its,development of PROMETHEUS...for irritable bowel syndrome (IBS). The findings s... particular biomarkers in blood samples,between IB...e biomarkers,combined with a proprietary algorith...
Breaking Medicine Technology:Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3How to treat gastroesophageal adenocarcinom patients 3F 26537 1How to treat gastroesophageal adenocarcinom patients 3F 26537 2Does probiotic intervention induce the serum global lipid profile change 3F 26535 1Does probiotic intervention induce the serum global lipid profile change 3F 26535 2Novel anti cancer mechanism found in long lived rodents 4942 1Novel anti cancer mechanism found in long lived rodents 4942 2Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday September 24th 3090 1Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday September 24th 3090 2
...Primate Study, CHICAGO, May 02, 2007 /PRNewswire-F... today announced that its novel respiratory,antibi...eventing,inhalation anthrax infection. This conclu...ay course of oral Cethromycin was 100%,protective ...ed to,the standard of care, Cipro(R) (ciprofloxaci...
... Accera Inc. is,presenting topline data today from...in Alzheimer,s disease (AD) at the American,Academ.... Judged by,the AAN to be in the top five percent ...the Scientific Highlights Plenary Session. , The r...e IIb,trial evaluated 152 subjects that had previo...
Other Medicine Technology:Cethromycin Shown Effective Against Anthrax in Study 2Cethromycin Shown Effective Against Anthrax in Study 3Cethromycin Shown Effective Against Anthrax in Study 4Accera, Inc. Announces Results of Phase II Study in Alzheimer's,Disease at American Academy of Neurology Meeting 2Accera, Inc. Announces Results of Phase II Study in Alzheimer's,Disease at American Academy of Neurology Meeting 3
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: